These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 13319594)
21. [Relation between zymosan, properdin & tumors. I. Effect of zymosan on the development of benzpyrene-induced sarcomas]. MODICA F Tumori; 1958; 44(6):538-48. PubMed ID: 13635872 [No Abstract] [Full Text] [Related]
22. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera. LAURELL AB; REYN A Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558 [No Abstract] [Full Text] [Related]
23. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera. LAURELL AB; REYN A Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557 [No Abstract] [Full Text] [Related]
24. [Properdin, a serum factor of importance for natural resistance]. BRO-RASMUSSEN F; KILLMANN SA Nord Med; 1956 Oct; 56(41):1479-82. PubMed ID: 13388106 [No Abstract] [Full Text] [Related]
25. [Properdin and natural immunity]. DE LA GARZA BRITO A Rev Sanid Milit; 1955; 8(7-9):200-1. PubMed ID: 13298269 [No Abstract] [Full Text] [Related]
26. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE. BLUM L J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548 [No Abstract] [Full Text] [Related]
27. [Properdin, serological factor of natural immunity]. FAYE CM Gaz Med Fr; 1956 Apr; 63(8):771-2. PubMed ID: 13318329 [No Abstract] [Full Text] [Related]
28. [THE ROLE OF THE PROPERDIN SYSTEM IN NON-SPECIFIC IMMUNITY]. HOSHINO A Nihon Naika Gakkai Zasshi; 1963 Dec; 52():1023-40. PubMed ID: 14158037 [No Abstract] [Full Text] [Related]
29. The properdin system and immunity. V. The bactericidal activity of the properdin system. WARDLAW AC; PILLEMER L J Exp Med; 1956 May; 103(5):553-75. PubMed ID: 13319578 [TBL] [Abstract][Full Text] [Related]
30. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs. BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461 [No Abstract] [Full Text] [Related]
31. [NATURAL INNATE IMMUNITY FOR BRUCELLA MELITENSIS. I. RELATION WITH PROPERDIN, COMPLEMENT, BACTERICIDAL PROPERTIES OF SERUM AND THE FORMATION OF SPECIFIC ANTIBODIES]. LEON AP; OSOLLO G; CANO C Rev Inst Salubr Enferm Trop; 1962 Dec; 22():145-72. PubMed ID: 14076958 [No Abstract] [Full Text] [Related]
32. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin. LAURELL AB Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839 [No Abstract] [Full Text] [Related]
33. Properdin and the defence of burns against infection. LOWBURY EJ; RICKETTS CR J Hyg (Lond); 1957 Jun; 55(2):266-75. PubMed ID: 13439176 [No Abstract] [Full Text] [Related]
34. [Properdin]. FERRARI F Boll Chim Farm; 1956 Jun; 95(6):258-66. PubMed ID: 13342173 [No Abstract] [Full Text] [Related]
35. An alternative mechanism for the properdin system. NELSON RA J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682 [TBL] [Abstract][Full Text] [Related]
36. [The usefulness of various zymosan preparations in determination of properdin]. von GRAEVENITZ ; HUSMANN KH; HOEBBEL K Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673 [No Abstract] [Full Text] [Related]
40. [Properdin and its immunological importance; present status of the question]. DELAUNAY A; HENON M; BAZIN S; PELLETIER M Presse Med (1893); 1956 Jan; 64(4):65-7. PubMed ID: 13289716 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]